Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
PTGS2
REST API REST API
Homo sapiens
PTGS2 is differentially expressed in 300 experiments: 117 organism parts: lung, prostate, ... (115 more);, 160 disease states: normal, control, ... (158 more);, 99 cell types 331 cell lines 50 compound treatments and 61 other conditions.
Synonyms COX2
Orthologs ptgs2b (Danio rerio)   ptgs2a (Danio rerio)   PGH2_CHICK (Gallus gallus)   Ptgs2 (Mus musculus)   Q9TVB3_BOVIN (Bos taurus)   ENSCING00000006498 (Ciona intestinalis)   ENSCING00000006154 (Ciona intestinalis)   Ptgs2 (Rattus norvegicus)   ptgs2 (Xenopus laevis)   NP_001003354.1 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term oxidoreductase activity, response to oxidative stress, positive regulation of nitric oxide biosynthetic process, endoplasmic reticulum, protein binding, cytoplasm, ovulation, cellular component movement, fatty acid biosynthetic process, memory, regulation of cell proliferation, negative regulation of cell proliferation, protein complex, membrane, peroxidase activity, prostaglandin metabolic process, lipid binding, metal ion binding, heme binding, positive regulation of apoptosis, neuron projection, oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen, microsome, regulation of cell cycle, nucleus, response to lipopolysaccharide, response to drug, endoplasmic reticulum membrane, enzyme binding, endoplasmic reticulum lumen, caveola, positive regulation of cell migration involved in sprouting angiogenesis, response to cytokine stimulus, prostaglandin-endoperoxide synthase activity, negative regulation of synaptic transmission, dopaminergic, response to vitamin D, response to organic nitrogen, xenobiotic metabolic process, positive regulation of smooth muscle contraction, bone mineralization, decidualization, negative regulation of calcium ion transport, cyclooxygenase pathway, anagen, prostaglandin biosynthetic process, response to estradiol stimulus, inflammatory response, regulation of blood pressure, regulation of inflammatory response, positive regulation of synaptic transmission, glutamatergic, positive regulation of prostaglandin biosynthetic process, response to organic substance, positive regulation of smooth muscle cell proliferation, brown fat cell differentiation, response to manganese ion, positive regulation vascular endothelial growth factor production, embryo implantation, positive regulation of synaptic plasticity, response to glucocorticoid stimulus, response to fructose stimulus, positive regulation of vasoconstriction, oxidation-reduction process, positive regulation of fibroblast growth factor production, positive regulation of brown fat cell differentiation, positive regulation of fever generation, response to organic cyclic compound, prostanoid metabolic process, positive regulation of platelet-derived growth factor production, positive regulation of transforming growth factor beta production
InterPro Term Haem_peroxidase_animal, EGF_3, Haem_peroxidase_animal_subgr
UniProt Accession P35354, Q6ZYK7, D9MWI3
Search EB-eye ENSG00000073756
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-17189, E-GEOD-803, E-GEOD-15765, E-GEOD-22541, E-GEOD-2549, ... (30 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-MEXP-1006, E-GEOD-19639, E-GEOD-18005, ... (34 experiments)

Factor Value U/D Experiments
SNU5
2
E-MTAB-37, E-GEOD-15460
A549
2
E-GEOD-3202, E-GEOD-6013
AGS
2
E-GEOD-15460, E-MTAB-37
MCF-7
2
E-GEOD-5823, E-GEOD-20081
MOLT4
2
E-MTAB-62, E-MTAB-37
SW480
2
E-MEXP-1014, E-GEOD-18005
325 more value(s).


Cell type

studied in E-GEOD-22529, E-GEOD-20193, E-GEOD-22373, E-GEOD-13909, E-TABM-34, ... (45 experiments)

Factor Value U/D Experiments
CD8+ T cell
3
E-AFMX-5, E-MTAB-25, E-GEOD-6740
CD33+ myeloid
2
E-AFMX-5, E-TABM-145
CD14+ monocyte
1
2
E-AFMX-5, E-MEXP-1600, E-TABM-145
macrophage
1
2
E-GEOD-22373, E-GEOD-5099, E-GEOD-3982
differentiated
1
E-GEOD-2649
mesenchymal stem cell
1
E-GEOD-9894
93 more value(s).


Disease state

studied in E-GEOD-15960, E-GEOD-2466, E-GEOD-16363, E-MTAB-62, E-MTAB-680, ... (58 experiments)

Factor Value U/D Experiments
prostate carcinoma
4
E-MEXP-2034, E-GEOD-7307, E-MTAB-62, E-GEOD-96
benign prostatic hyperplasia
2
E-MEXP-2034, E-MEXP-1243
cervical carcinoma
2
E-MTAB-62, E-GEOD-5823
colon carcinoma
2
E-GEOD-3726, E-MTAB-62
adrenocortical adenoma
1
E-GEOD-10927
adenomyosis
1
E-GEOD-7307
154 more value(s).


Compound treatment

studied in E-TABM-782, E-GEOD-3720, E-GEOD-4748, E-TABM-868, E-GEOD-3140, ... (29 experiments)

Factor Value U/D Experiments
lipopolysaccharide
5
E-TABM-868, E-GEOD-3140, E-MEXP-1958, E-GEOD-4748, E-GEOD-3720 ... (5 experiments)
5-aza-2'-deoxycytidine
2
1
E-MEXP-1269
sapphyrin PCI-2052
1
E-GEOD-6400
mercury dichloride
1
E-GEOD-6907
metoprolol
1
E-GEOD-3356
sapphyrin PCI-2051
1
E-GEOD-6400
44 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-22097, E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363, ... (6 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-MEXP-1251, E-GEOD-2034, E-GEOD-21589, ... (7 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-19743, E-GEOD-1614, E-GEOD-20033, E-MEXP-2359, E-MEXP-2283, ... (6 experiments)

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-GEOD-22148, E-TABM-147, E-GEOD-19665, ... (6 experiments)

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518, E-GEOD-3720

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-16363

Genetic modification
studied in E-GEOD-8023, E-GEOD-7011, E-GEOD-7578, E-GEOD-20847, E-GEOD-361, ... (7 experiments)

Genotype
studied in E-GEOD-1923, E-GEOD-2466, E-GEOD-2292, E-TABM-868, E-TABM-601, ... (10 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-5809, E-GEOD-5681, E-GEOD-20540, E-GEOD-22278, E-GEOD-3003, ... (15 experiments)

Histology
studied in E-GEOD-16194, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-GEOD-1926, E-MEXP-2069, E-MEXP-1648, ... (27 experiments)

Infection
studied in E-GEOD-2405, E-GEOD-12108, E-GEOD-9723, E-MEXP-561, E-GEOD-980, ... (8 experiments)

Injury
studied in E-GEOD-19743

Localisation of metastases
studied in E-GEOD-22541

Lymph node status
studied in E-GEOD-6532

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Organism
studied in E-GEOD-7540, E-GEOD-426, E-TABM-84

Organism status
studied in E-GEOD-19188

Phenotype
studied in E-GEOD-1493, E-GEOD-21750, E-GEOD-1657, E-GEOD-17636, E-GEOD-923, ... (6 experiments)

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246, ... (6 experiments)

Qpcr egfr dct
studied in E-GEOD-5851

Replicate
studied in E-GEOD-10896

RNAi
studied in E-GEOD-1703, E-GEOD-12438, E-MEXP-548, E-GEOD-3697

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-21164, E-GEOD-19743, E-GEOD-21374, E-MEXP-70, E-GEOD-17400, ... (6 experiments)

Sex
studied in E-GEOD-2466

Stimulation
studied in E-GEOD-4883, E-GEOD-20114, E-GEOD-11886, E-GEOD-11428, E-GEOD-12710 ... (5 experiments)

stimulus
studied in E-GEOD-22103

Strain or line
studied in E-MEXP-1996, E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-4922, E-GEOD-19188

targeted_cell_type
studied in E-MEXP-70

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-TABM-276

tissue (organ)
studied in E-GEOD-22601

Treatment
studied in E-GEOD-16193, E-GEOD-16837, E-GEOD-15799, E-GEOD-12198

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-1561, E-GEOD-4922

Processing time: 0.296 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM